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Identify methicillin-resistant Staphylococcus aureus
nasal carriers in hemodialysis patients
Wang et al1 reported in the Journal of the Formosan
Medical Association the prevalence rate of methicillin-
resistant Staphylococcus aureus (MRSA) nasal colonization
in hemodialysis (HD) patients in Taiwan was 5.9%, which
was nearly one-half of those reported by Lederer et al.2
from Germany. However, the methods of detecting MRSA
carriage were different in these two studies: the former
used one single nasal swab culture, while the later used at
least two (varied between two and 10) nasal swab screen-
ings. It is inappropriate to compare a prevalence rate by
using different detecting strategies.
Our previous report detected MRSA carriers by per-
forming two consecutive nasal swab cultures obtained at
a 1-week interval in another tertiary medical center in
northern Taiwan.3 Those who had at least one positive
culture of MRSA were defined as MRSA carriers. We found
the prevalence of MRSA nasal carriage in HD patients was
9.48%. In detail, there were 13 (4.25%) persistent carriers
and 16 (5.23%) intermittent carriers. Following this paper,
serial annual surveillance of MRSA nasal carriage in our HD
patients still identified these two patterns of MRSA carriers
(Table 1). Using only one examination may fail to identifyTable 1 Prevalence rate of MRSA nasal carriers in hemo-
dialysis patients.a
Year 2007 2008 2009 2010
MRSA carriageb
MRSA carrier 9.48% 5.04% 5.57% 3.51%
Persistent carrier 4.25% 2.10% 4.11% 2.92%
Intermittent carrier 5.23% 2.94% 1.47% 0.58%
MRSA Z methicillin-resistant Staphylococcus aureus.
a Annually survey in the outpatient hemodialysis unit of Far
Eastern Memorial Hospital. Decolonization therapy by mupir-
ocin was adapted since 2008.
b Carriage was detected by performing two consecutive nasal
swab cultures obtained at a 1-week interval. Those who had at
least one positive culture of MRSA were defined as a MRSA
carrier. A person was classed as a persistent carrier when both
of the cultures were positive in that survey. The person was
considered an intermittent carrier when only one of the
cultures was positive.
0929-6646/$ - see front matter Copyright ª 2012, Elsevier Taiwan LLC
http://dx.doi.org/10.1016/j.jfma.2012.07.009a significant portion of MRSA carriers. Similar findings were
also shown in other studies to detect S. aureus carrier-
ship.4,5 Therefore, we suggest screening of MRSA nasal
carriage in HD patients should be carried out by at least two
consecutive weekly nasal swab cultures in order to maxi-
mize the probability of identifying all MRSA carriers.
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